National- and State-Level Pharmacy-Based Buprenorphine Dispensing, United States 2019-2021

J Gen Intern Med. 2024 Aug;39(10):1951-1953. doi: 10.1007/s11606-024-08829-0. Epub 2024 May 28.

Authors

Chase L Barham¹, Andrea E Strahan², Kun Zhang², Gery P Guy Jr²

Affiliations

¹ Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA. [email protected].
² Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Atlanta, GA, USA.

PMID: 38806799
PMCID: PMC11282010 (available on 2025-08-01)
DOI: 10.1007/s11606-024-08829-0

No abstract available

Publication types

Letter

MeSH terms

Adult
Buprenorphine* / therapeutic use
Drug Prescriptions / statistics & numerical data
Female
Humans
Male
Middle Aged
Narcotic Antagonists / therapeutic use
Opiate Substitution Treatment* / methods
Opiate Substitution Treatment* / trends
Opioid-Related Disorders* / drug therapy
Vereinigte Staaten

Substances

Buprenorphine
Narcotic Antagonists